ATE332371T1 - Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese - Google Patents
Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresyntheseInfo
- Publication number
- ATE332371T1 ATE332371T1 AT00943373T AT00943373T ATE332371T1 AT E332371 T1 ATE332371 T1 AT E332371T1 AT 00943373 T AT00943373 T AT 00943373T AT 00943373 T AT00943373 T AT 00943373T AT E332371 T1 ATE332371 T1 AT E332371T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- synthesis
- relates
- inhibitors
- compositions
- Prior art date
Links
- 238000001668 nucleic acid synthesis Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000035945 sensitivity Effects 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 7
- 108020004707 nucleic acids Proteins 0.000 abstract 7
- 150000007523 nucleic acids Chemical class 0.000 abstract 7
- 239000003112 inhibitor Substances 0.000 abstract 5
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 230000005764 inhibitory process Effects 0.000 abstract 3
- 238000012163 sequencing technique Methods 0.000 abstract 3
- 238000003786 synthesis reaction Methods 0.000 abstract 3
- 230000003321 amplification Effects 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- AIDS & HIV (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14207299P | 1999-07-02 | 1999-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332371T1 true ATE332371T1 (de) | 2006-07-15 |
Family
ID=22498453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00943373T ATE332371T1 (de) | 1999-07-02 | 2000-06-30 | Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1196559B1 (https=) |
| JP (2) | JP2003504018A (https=) |
| AT (1) | ATE332371T1 (https=) |
| AU (1) | AU782555B2 (https=) |
| CA (1) | CA2377780A1 (https=) |
| DE (1) | DE60029225T2 (https=) |
| NZ (1) | NZ516894A (https=) |
| WO (1) | WO2001002559A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002064833A1 (en) | 2001-02-15 | 2002-08-22 | Takara Bio Inc. | Method of detecting nucleotide polymorphism |
| EP2330194A3 (en) * | 2002-09-13 | 2011-10-12 | Replicor, Inc. | Non-sequence complementary antiviral oligonucleotides |
| EP1802774B1 (en) * | 2004-10-18 | 2012-01-11 | Brandeis University | Reagents and methods for improving reproducibility and reducing mispriming in pcr amplification |
| WO2007038422A2 (en) | 2005-09-26 | 2007-04-05 | Allelogic Biosciences Corp. | Oligonucleotides as temperature-sensitive inhibitors for dna polymerases |
| EP2458011B1 (en) | 2005-10-03 | 2013-07-24 | Life Technologies Corporation | Compositions, methods, and kits for amplifying nucleic acids |
| US7781165B2 (en) | 2005-10-19 | 2010-08-24 | Roche Diagnostics Operations, Inc. | Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification |
| JPWO2012070618A1 (ja) | 2010-11-24 | 2014-05-19 | 株式会社カネカ | 増幅核酸検出方法及び検出デバイス |
| WO2013154898A1 (en) * | 2012-04-12 | 2013-10-17 | Ong, Jennifer | Synthetic nucleic acids for polymerization reactions |
| WO2013162026A1 (ja) * | 2012-04-27 | 2013-10-31 | 株式会社カネカ | 核酸の増幅方法、および、増幅核酸の検出方法 |
| US10392652B2 (en) | 2013-11-22 | 2019-08-27 | Kaneka Corporation | Micro RNA detection method using two primers to produce an amplified double stranded DNA fragment having a single stranded region at one end |
| JP7323534B2 (ja) * | 2018-01-05 | 2023-08-08 | ストラトス ゲノミクス インコーポレイテッド | 芳香族化合物による核酸重合の強化 |
| KR102275038B1 (ko) * | 2019-12-11 | 2021-07-08 | (주) 제노텍 | 대립 유전자의 구분성을 높이는 pcr 방법 및 pcr 킷트 |
| JP2023531027A (ja) * | 2020-06-22 | 2023-07-20 | ▲蘇▼州新海生物科技股▲ふん▼有限公司 | 核酸リガンド、およびその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763173A (en) * | 1990-06-11 | 1998-06-09 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand inhibitors to DNA polymerases |
| DE69638318D1 (de) * | 1995-06-07 | 2011-02-17 | Gilead Sciences Inc | Nukleinsäureliganden, die an DNA-Polymerasen binden und diese inhibieren |
| US5760012A (en) * | 1996-05-01 | 1998-06-02 | Thomas Jefferson University | Methods and compounds for curing diseases caused by mutations |
-
2000
- 2000-06-30 AU AU57850/00A patent/AU782555B2/en not_active Ceased
- 2000-06-30 EP EP00943373A patent/EP1196559B1/en not_active Expired - Lifetime
- 2000-06-30 CA CA002377780A patent/CA2377780A1/en not_active Abandoned
- 2000-06-30 NZ NZ516894A patent/NZ516894A/en unknown
- 2000-06-30 AT AT00943373T patent/ATE332371T1/de not_active IP Right Cessation
- 2000-06-30 DE DE60029225T patent/DE60029225T2/de not_active Expired - Lifetime
- 2000-06-30 JP JP2001508332A patent/JP2003504018A/ja active Pending
- 2000-06-30 WO PCT/US2000/018256 patent/WO2001002559A1/en not_active Ceased
-
2010
- 2010-10-15 JP JP2010232252A patent/JP2011041572A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE60029225T2 (de) | 2007-07-05 |
| JP2003504018A (ja) | 2003-02-04 |
| CA2377780A1 (en) | 2001-01-11 |
| AU782555B2 (en) | 2005-08-11 |
| AU5785000A (en) | 2001-01-22 |
| WO2001002559A1 (en) | 2001-01-11 |
| EP1196559B1 (en) | 2006-07-05 |
| WO2001002559A9 (en) | 2002-07-25 |
| JP2011041572A (ja) | 2011-03-03 |
| EP1196559A1 (en) | 2002-04-17 |
| NZ516894A (en) | 2004-06-25 |
| DE60029225D1 (de) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Martin et al. | Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies | |
| DE60029225D1 (de) | Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese | |
| ATE167680T1 (de) | Pteridin-nukleotidderivate als fluoreszierende sonden | |
| Wang et al. | RNA Conformation in the Tat− TAR Complex Determined by Site-Specific Photo-Cross-Linking | |
| Ohtsuki et al. | The minimal tRNA: unique structure of Ascaris suum mitochondrial tRNASerUCU having a short T arm and lacking the entire D arm | |
| ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
| DE60131903D1 (de) | Direkte multiplex charakterisierung von genomischer dna | |
| NO973685L (no) | Multi-tumor avvikende vekstgener | |
| DK0587266T3 (da) | Fremgangsmåde, sammensætning og kit til nukleinsyreamplifikation | |
| ATE269402T1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
| TR199802385T2 (xx) | TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler. | |
| DK0519053T3 (da) | Nucleinsyreamplifikation med DNA-afhængig RNA-polymeraseaktivitet hos RNA-replicaser | |
| DE59914254D1 (de) | Polymerasenchimären | |
| Ramon et al. | Effects of 8-oxo-7, 8-dihydro-2′-deoxyguanosine on the binding of the transcription factor Sp1 to its cognate target DNA sequence (GC box) | |
| DE60132924D1 (de) | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) | |
| AU4345401A (en) | Nucleic acid sensor molecules | |
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| ATE255595T1 (de) | Nephrin gen und protein | |
| DE69732857D1 (de) | Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen | |
| Kolpashchikov et al. | Synthesis of base-substituted dUTP analogues carrying a photoreactive group and their application to study human replication protein A | |
| ATE174634T1 (de) | Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern | |
| DE60025011D1 (de) | Dna polymerase lambda und ihre verwendungen | |
| BRPI0407292A (pt) | Uso de um ácido nucleico, da correlação direta entre a super-expressão ou a modificação molecular funcional de homólogos humanos da famìlia sgk e a extensão do intervalo q/t, de um anticorpo dirigido contra um substrato de um homólogo humano da famìlia sgk, de um ativador funcional, ou de um regulador de transcrição positivo, de um homólogo humano da famìlia sgk e uso de substâncias selecionadas dentre o grupo consistindo de glucocorticóides, mineralocorticóides, aldosterona, gonadotropinas e citocinas, kit e método para diagnosticar hipertensão, kit para diagnosticar a sìndrome de qt longo e fármaco | |
| Inga et al. | N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic | |
| DE60040874D1 (de) | Amplifizierung von hiv-1 sequenzen zur detektion ven einhergehen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |